Altered signaling triggered by ligation of the TCR/CD3 receptor in T lymphocytes from patients with systemic lupus erythematosus: The road from anergy to autoimmunity

International Reviews of Immunology

Volumn 23, Issue 3-4, 2004, Pages 265-272

  Blasini, Ana M ^a,b   Rodríguez, Martín A ^a,c  

^a HOSPITAL UNIVERSITARIO DE CARACAS   (Venezuela)

^b UNIVERSIDAD CENTRAL DE VENEZUELA   (Venezuela)

^c POBA International 1 20227 ^*  (United States)

Author keywords

Anergy; Signaling; SLE; T cells

Indexed keywords

CD3 ANTIGEN; LIGAND; T LYMPHOCYTE RECEPTOR;

AUTOIMMUNITY; CLONAL ANERGY; HUMAN; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION;

EID: 3042571367     PISSN: 08830185     EISSN: None     Source Type: Journal    
DOI: 10.1080/08830180490452594-17     Document Type: Review

References (47)

1. J. Alcocer-Varela and D. Alarcon-Segovia, Decreased production of and response to interleukin-2 by cultured lymphocytes from patients with systemic lupus erythematosus, J. Clin. Invest., 69: 1388-1392, 1982.
2. M. Linker-Israeli, A.C. Bakke, R.C. Kitridou, S. Gendler, G. Gillis, and D.A. Horwitz, Defective production of interleukin 1 and 2 in patients with systemic lupus erythematosus (SLE), J. Immunol., 130: 2651-2655, 1983.
3. E.E. Solomon, Y.T. Juang, M.F. Gourley, G.M. Kammer, and G.C. Tsokos, Molecular basis of deficient IL-2 production in T cells from patients with systemic lupus erythematosus, J. Immunol., 166: 4216-4222, 2001.
4. I.L. Stekman, A.M. Blasini, M. Leon-Ponte, M.L, Baroja, I. Abadí, and M.A. Rodriguez, Enhanced CD3-mediated T lymphocyte proliferation in patients with systemic lupus erithematosus, Arthritis Rheum., 34: 459-467, 1991.
5. B. Kovacs, D. Vassilopoulos, S.A. Vogelgesang, and G.S. Tsokos, Defective CD3-mediated cell death in activated T cells from patients with systemic lupus erythematosus: Role of decreased intracellular TNF-alpha, Clin. Immunol. Immunopathol., 81: 293-302, 1996.
6. T.W. McKeithan, Kinetic proofreading in T-cell receptor signal transduction, Proc. Natl. Acad. Sci. USA, 92: 5042-5046, 1995.
7. J.D. Rabinowitz, D.C. Beeson, D.S. Lyons, M.M. Davis, and H.M. McConnell, Kinetic discrimination in T-cell activation, Proc. Natl. Acad. Sci. USA, 93: 1401-1405, 1996.
8. + T cells, J. Immunol., 151: 2355-2367, 1993.
9. Y. Boutin, D. Leitenberg, X. Tao, and K. Bottomly, Distinct biochemical signals characterize agonist- and altered peptide ligand-induced differentiation of naive CD4+ T cells into Th1 and Th2 subsets, J. Immunol., 159: 5802-5809, 1997.
10. D.C. Tsitoura, W. Holter, A. Cerwenka, C.M. Gelder, and J.R. Lamb, Induction of anergy in human T helper O cells by stimulation with altered T cell antigen receptor ligands, J. Immunol., 156: 2801-2808, 1996.
11. L.C. Korb, S. Mirshahidi, K. Ramyar, A.A.S. Akha, and S. Sadegh-Nasseri, Induction of T cell anergy by low numbers of agonist ligands, J. Immunol., 162: 6401-6409, 1999.
12. K. Migita, K. Eguchi, Y. Kawabe, T. Tsukada, Y. Ichinose, and S. Nagataki, Defective TCR-mediated signaling in anergic T cells, J. Immunol., 155: 5083-5087, 1995 K.
13. K. Salojin, J. Zhang, M. Cameron, B. Gill, G. Arreaza, A. Ochi, and T.L. Delovitch, Impaired plasma membrane targeting of Grb2-murine Son of Sevenless (mSOS) complex and differential activation of the Fyn-T cell receptor (TCR)-ζ-Cbl pathway mediated T cell hyporesponsivennes in autoimmune nonobese diabetic mice, J. Exp. Med., 186: 887-897, 1997.
14. K.V. Salojin, J. Zhang, J. Madrenas, and T.L. Delovitch, T-cell anergy and altered T-cell receptor signaling: Effects on autoimmune disease, Immunol. Today, 19: 468-473, 1998.
15. S.I. Gringhuis, A. Leow, E.A.M. Papendrecht-vander Voort, P.H.J. Remans, F.C. Breedveld, and C.L. Verweij, Displacement of linker for activation of T cells from the plasma membrane due to redox balance alterations results in hyporesponsiveness of synovial fluid T lymphocytes in rheumatoid arthritis, J. Immunol., 164: 2170-2179, 2000.
16. S.N.C. Liossis, X.Z. Ding, G.J. Dennis, and G.S. Tsokos, Altered pattern of TCR/CD3-mediated protein-tyrosyl phosphorylation in T cells from patients with systemic lupus erythematosus. Deficient expression of the T cell receptor zeta chain, J. Clin. Invest., 101: 1448-1457, 1998.
17. V. Brundula, L. Rivas, A.M. Blasini, M. Paris, S. Salazar, I.L. Stekman, and M.A. Rodriguez, Diminished levels of TCR ζ chain in peripheral blood (PB) T lymphocytes from patients with systemic lupus erithematosus (SLE), Arthritis Rheum., 42: 1908-1916, 1999.
18. J.D. Klemm, S.L. Schreiber, and G.R. Crabtree, Dimerization as a regulatory mechanism in signal transduction, Ann. Rev. Immunol., 16: 569-592, 1998.
19. E.N. Kersh, A.S. Shaw, and P.M. Allen, Fidelity of T cell activation through multistep T cell receptor ζ phosphorylation, Science, 281: 572-575, 1998.
20. B. Johansson, E. Palmer, and L. Bolliger, The extracellular domain of the ζ-chain is essential for TCR function, J. Immunol., 162: 878-885, 1999.
21. B. Combadiere, M. Freedman, L. Chen, E.W. Shores, P. Love, and M.J. Lenardo, Qualitative and quantitative contributions of the T cell receptor ζ chain to mature T cell apoptosis, J. Exp. Med., 183: 2109-2117, 1996.
22. K. Tsuzaka, T. Takeuchi, M. Pang, N. Onoda, and T. Abe, Mutations in T cell receptor ζ chain mRNA of peripheral T cells from systemic lupus erythematosus, J. Autoimmun., 11: 381-385, 1998.
23. M.P. Nambiar, E.J. Enyedi, V.G Warke, S. Krishnan, G. Dennis, H.K. Wong, G.M. Kammer, and G.S. Tsokos, T cell signaling abnormalities in systemic lupus erythematosus are associated with increased mutations/polymorphisms and splice variants of T cell receptor ζ chain messenger, Arthritis Rheum., 44: 1336-1350, 2001.
24. G.M. Kammer, A. Perl, B.C. Richardson, and G.C. Tsokos, Abnormal T cell signal transduction in systemic lupus erythematosus, Arthritis Rheum., 46: 1139-1154, 2002.
25. A.M. Blasini, R. Chacon, R. Riera, I.L. Stekman, and M.A. Rodriguez, Abnormal pattern of tyrosine phosphorylation in unstimulated peripheral blood T lymphocytes form patients with systemic lupus erythematosus, Lupus, 7: 515-523, 1998.
26. M. Matache, M. Stefanescu, A. Onu, G. Szegli, M. Barel, S. Tanseanu, I. Matei, S. Bouillie, and R. Frade, Tyrosine phosphorylation in peripheral lymphocytes from patients with systemic lupus erythematosus, Autoimmunity, 24: 217-228, 1996.
27. E.J. Enyedi, M.P. Nambiar, H.K. S.N.C. Liossis, G. Dennis, G.M. Kammer, and G.C. Tsokos, Fcε receptor type I γ chain replaces the deficient T cell receptor ζ chain in T cells of patients with systemic lupus erythematosus, Arthritis Rheum., 44: 1114-1121, 2001.
28. A.M. Blasini, V. Brundula, M. Paris, L. Rivas, S, Salazar, I.L. Stekman, and M.A. Rodriguez, Protein tyrosine kinase activity in T lymphocytes from patients with systemic lupus erythematosus, J. Autoimmun., 11: 387-393, 1998.
29. T. Katagiri, J.P. Ting, R. Dy, C. Prokop, P. Cohen, and H.S. Earp, Tyrosine phosphorylation of a c-src like protein is increased in membranes of CD4-CD8-T lymphocytes from lpr/lpr mice, Mol. Cell. Biol., 9: 4914-4922, 1989.
30. fyn, J. Immunol., 149: 2887-2893, 1992.
31. J. Huang, D. Tilly, A. Altman, K. Sugie, and H.M. Grey, T-cell receptor antagonists induce Vav phophorylation by selective activation of fyn kinase, Proc. Natl. Acad. Sci. USA, 97: 10923-10929, 2000.
32. A. Cherukuri, M. Dykstra, and S.K. Pierce, Floating the raft hypothesis: Lipid rafts play a role in immune cell activation, Immunity, 14: 657-660, 2001.
33. L.E. Samelson, A.F. Phillips, E.T. Wong, and R.D. Klausner, Association of the fyn protein-tyrosine kinase with the T-cell antigen receptor, Proc. Natl. Acad. Sci. USA, 87: 4358-4362, 1990.
34. T. Takeuchi, M. Pang, K. Amano, J. Koide, and T. Abe, Reduced protein tyrosine phosphatase (PTPase) activity of CD45 on peripheral blood lymphocytes in patients with systemic lupus erythematosus (SE), Clin. Exp. Immunol., 109: 20-26, 1997.
35. M.L. Hermiston, X. Zheng, R. Majeti, and A. Weiss. Reciprocal regulation of lymphocyte activation by tyrosine kinases and phosphatases, J. Clin. Invest., 109: 9-14, 2002.
36. M.P. Nambiar, E.J. Enyedy, C.U. Fisher, S. Krishnan, V.G. Warke, W.R. Gilliland, R.J. Oglesby, and G.S. Tsokos, Abnormal expression of various molecular forms and distribution of T cell receptor ζ chain in patients with systemic lupus erythematosus, Arthritis Rheum., 46: 163-174, 2002.
37. A. Leo, J. Wienands, G. Baier, V. Horejsi, and B. Schraven, Adapters in lymphocyte signaling, J. Clin. Invest., 109: 301-309, 2002.
38. W. Zhang, R.P. Trible, M. Zhu, S.K. Liu, C.J. McGlade, and L.E. Samelson, Association of Grb2, Gads, and phospholipase C-gamma 1 with phosphorylated LAT tyrosine residues. Effect of LAT tyrosine mutations on T cell antigen receptor-mediated signaling, J. Biol. Chem., 275: 2335-2336, 2000.
39. S. Cedeno, D.F. Cifarelli, A.M. Blasini, M. Paris, F. Placeres, G. Alonso, M.A. Rodríguez. Defective activity of ERK-1 and ERK-2 mitogen-activated protein kinases in peripheral blood T lymphocytes from patients with systemic lupus erythematosus: potential role of altered coupling of Ras nucleotide exchange factor hSos to adapter protein Grb2 lupus T cells, Clin. Immunol., 106: 41-49, 2003.
40. C. Deng, M.J. Kaplan, J. Yang, D. Ray, Z. Zhang, W.J. McCune, S.M. Hanash, and B.C. Richardson, Decreased Ras-mitogen-activated protein kinase signaling may cause DNA hypomethylation in T lymphocytes from lupus patients, Arthritis Rheum. 44: 397-407, 2001.
41. W. Li, C.D. Whaley, A. Mondino, and D.L. Mueller, Blocked signal transduction to the ERK and JNK protein kinases in anergic CD4+ T cells, Science, 271: 1272-1276, 1996.
42. P.E. Fields, T.F. Gajewski, and F.W. Fitch, Blocked Ras activation in anergic CD4+ T cells, Science, 271: 1276-1278, 1996.
43. I. Horak, J. Lohler, A. Ma, and K.A. Smith, Interleukin-2 deficient mice: A new model to study autoimmunity and self-tolerance, Immunol. Rev., 148: 35-44, 1995.
44. H. Suzuki, T.M. Kundig, C. Furlonger, A. Wakeman, E. Timms, T. Matsuyama, R. Schmits, J.J. Simard, P.S. Ohashi, H. Griesser, T. Taniguchi, C.J. Paige, T.W. Mak. Deregulated T cell activation and autoimmunity in mice lacking interleukin-2 receptor beta, Science, 9: 1472-1476, 1995.
45. T.R. Malek, B.O. Porter, E.K. Codias, P. Sciberlli, and A. Yu, Normal lymphoid homeostasis and lack of lethal autoimmunity in mice containing mature T cells with severely impaired IL-2 receptors, J. Immunol., 15: 2905-2914, 2000.
46. B.R. Ludviksson, B. Gray, W. Strober, and R.O. Ehrhardt, Dysregulated intrathymic development in the IL-2-deficient mouse leads to colitis-inducing thymocytes, J. Immunol., 158: 104-11, 1997.
47. L.G. Radvanyi, K. Raju, D. Spaner, G.B. Mills, and R.G. Miller, Interleukin-2 reverses the defect in activation-induced apoptosis in T cells from autoimmune lpr mice, Cell. Immunol., 183: 1-12, 1998.